Concepedia

O. Sartor

OS

Statistics

Publications

4

Citations

69

H-Index

4

Active since

2019

Affiliations

Cornell University(Current)

BC Cancer Agency

Washington University in St. Louis

Carolina Urologic Research Center

Princess Margaret Cancer Centre

O. Sartor is an author at Cornell University specializing in oncology, medicine, and psma-targeted therapy.

Publications per year

2019–2025

4

Publications

4

LBA6 Phase III trial of [177Lu]Lu-PSMA-617 combined with ADT + ARPI in patients with PSMA-positive metastatic hormone-sensitive prostate cancer (PSMAddition)

S.T. Tagawa, O. Sartor, J.M. Piulats et al. · Annals of Oncology · 2025 · 21 citations · Full text

, , +14

PROfound: Phase III study of olaparib versus enzalutamide or abiraterone for metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene alterations

Shahneen Sandhu, M. Hussain, J. Mateo et al. · Annals of Oncology · 2019 · 18 citations · Full text

, , +17

LBA65 Efficacy of 177Lu-PNT2002 in PSMA-positive mCRPC following progression on an androgen-receptor pathway inhibitor (ARPI) (SPLASH)

O. Sartor, Di Jiang, M. Smoragiewicz et al. · Annals of Oncology · 2024 · 17 citations

, , +15

1400P Efficacy and safety of 177Lu-PNT2002 prostate-specific membrane antigen (PSMA) therapy in metastatic castration resistant prostate cancer (mCRPC): Initial results from SPLASH

A.R. Hansen, S. Probst, R.F. Tutrone et al. · Annals of Oncology · 2022 · 13 citations

, , +16

1–4 of 4